Literature DB >> 22226095

Supportive care of hematopoietic cell transplant patients.

Heather S L Jim1, Karen L Syrjala, Doug Rizzo.   

Abstract

Hematopoietic cell transplant survivors face a number of challenges including low energy and stamina, "chemo-brain" and emotional distress, and late effects that can compromise functioning or lead to early mortality. This session will review the most recent interventions and recommendations to avoid or mitigate these complications.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 22226095      PMCID： PMC3445407          DOI： 10.1016/j.bbmt.2011.10.029

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


  22 in total

1.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).

Authors:  J D Rizzo; J R Wingard; A Tichelli; S J Lee; M T Van Lint; L J Burns; S M Davies; J L M Ferrara; G Socié
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

2.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.

Authors:  J Douglas Rizzo; John R Wingard; Andre Tichelli; Stephanie J Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

3.  Routine screening for psychosocial distress following hematopoietic stem cell transplantation.

Authors:  S J Lee; F R Loberiza; J H Antin; T Kirkpatrick; L Prokop; E P Alyea; C Cutler; V T Ho; P G Richardson; R L Schlossman; D C Fisher; B Logan; R J Soiffer
Journal:  Bone Marrow Transplant       Date:  2005-01       Impact factor: 5.483

4.  Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.

Authors:  N Sarhill; D Walsh; K A Nelson; J Homsi; S LeGrand; M P Davis
Journal:  Am J Hosp Palliat Care       Date:  2001 May-Jun       Impact factor: 2.500

5.  Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.

Authors:  Fausto R Loberiza; J Douglas Rizzo; Christopher N Bredeson; Joseph H Antin; Mary M Horowitz; Jane C Weeks; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

6.  Comparison of lasting life changes after cancer and BMT: perspectives of long-term survivors and spouses.

Authors:  Michelle M Bishop; Barbara A Curbow; Shauna H Springer; Jocelyn A Lee; John R Wingard
Journal:  Psychooncology       Date:  2010-08-04       Impact factor: 3.894

7.  A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation.

Authors:  F T Baumann; L Kraut; K Schüle; W Bloch; A A Fauser
Journal:  Bone Marrow Transplant       Date:  2009-07-13       Impact factor: 5.483

8.  Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.

Authors:  Alicia Collado-Hidalgo; Julienne E Bower; Patricia A Ganz; Michael R Irwin; Steve W Cole
Journal:  Brain Behav Immun       Date:  2008-07-09       Impact factor: 7.217

9.  Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.

Authors:  Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry Storer; Jean E Sanders; Mary E D Flowers; Paul J Martin
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

Review 10.  Quality of life after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113
View more
  6 in total

1.  A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors.

Authors:  Lisa M Wu; Nadia Kuprian; Krista Herbert; Ali Amidi; Jane Austin; Heiddis Valdimarsdottir; Christine Rini
Journal:  Palliat Support Care       Date:  2019-08

2.  Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.

Authors:  Matthias Naegele; Monika Kirsch; Gabriele Ihorst; Katharina Fierz; Monika Engelhardt; Sabina De Geest
Journal:  Support Care Cancer       Date:  2017-09-16       Impact factor: 3.603

3.  High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age.

Authors:  J Hefner; M Kapp; K Drebinger; A Dannenmann; H Einsele; G-U Grigoleit; H Faller; H Csef; S Mielke
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

4.  Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantation.

Authors:  Zev M Nakamura; Allison M Deal; Donald L Rosenstein; Laura J Quillen; Stephanie A Chien; William A Wood; Thomas C Shea; Eliza M Park
Journal:  Contemp Clin Trials       Date:  2020-06-30       Impact factor: 2.226

5.  Feasibility of a Digital Storytelling Intervention for Hematopoietic Cell Transplant Patients.

Authors:  Wonsun Sunny Kim; Shelby Langer; Michael Todd; Linda Larkey; Soojung Jo; Lauren R Bangerter; Nandita Khera
Journal:  J Cancer Educ       Date:  2021-01-03       Impact factor: 1.771

6.  Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant.

Authors:  Natalie L Wu; Amanda I Phipps; Kevin R Krull; Karen L Syrjala; Paul A Carpenter; Laura S Connelly-Smith; Mary E Flowers; Elizabeth F Krakow; Masumi Ueda Oshima; Stephanie J Lee; Eric J Chow
Journal:  Blood Adv       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.